Fortress Biotech Inc. (FBIO) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Fortress Biotech Inc. (FBIO:NASDAQ), powered by AI.

Current Price
$2.93
P/E Ratio
12.0
Market Cap
82M
Sector
Healthcare
What is the Fortress Biotech Inc. stock price forecast?

Fortress Biotech Inc. is currently trading at $2.93. View real-time AI analysis on Alpha Lenz.

What is Fortress Biotech Inc. insider trading activity?

View the latest insider trading data for Fortress Biotech Inc. on Alpha Lenz.

What is Fortress Biotech Inc.'s P/E ratio?

Fortress Biotech Inc.'s P/E ratio is 12.0.

Fortress Biotech Inc.

NASDAQ · FBIO
$2.93+0.07(+2.45%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Fortress Biotech Inc.'s future dividend policy...
Alpha Chat Insight

Fortress Biotech Inc. trades at a P/E of 12.0 (undervalued) with strong ROE of 18.8%.

Ask for details

Company Overview

Fortress Biotech Inc. operates as a biopharmaceutical company involved in the development and commercialization of novel pharmaceutical and biotechnology products. Its primary function is to nurture and advance a diverse portfolio of potential new treatments for rare diseases, cancer, and other serious health conditions. A distinctive feature of Fortress Biotech is its innovative partnership model; it acquires, develops, and commercializes these therapies through multiple subsidiary companies and licensing agreements. This structure allows for specialized focus and flexibility in progressing early-stage drug candidates. Fortress Biotech significantly impacts the healthcare sector, particularly in areas of unmet medical needs where it seeks to bring breakthrough therapies to market. By creating a platform for research and development across its subsidiaries, the company plays a crucial role in fostering advancements in medical treatments and addressing critical gaps within pharmaceutical innovation and patient care.

CEODr. Lindsay Allan Rosenwald M.D.
SectorHealthcare
IndustryBiotechnology
Employees101

Company Statistics

FY 2025

Profile

$81.75MMarket Cap
$63.26MRevenue
0.00Shares Out
101Employees

Margins

66.92%Gross
-74.13%EBITDA
-111.00%Operating
-53.01%Pre-Tax
-52.03%Net

Valuation

12.00P/E
1.64P/B
1.29EV/Sales
-1.90EV/EBITDA
-1.24P/FCF

Growth (CAGR)

-5.83%Rev 3Yr
6.77%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-19.96%ROA
18.77%ROE
-15.06%ROIC

Financial Health

$79.38MCash & Cash Equivalents
$43.98MNet Debt
198.39%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Fortress Biotech Inc. (ticker: FBIO) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 101 employees. Market cap is $82M.

The current price is $2.93 with a P/E ratio of 12x and P/B of 1.64x.

ROE is 18.77% and operating margin is -111.00%. Annual revenue is $63M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Fortress Biotech Inc. (FBIO) Stock Forecast 2026 $2.93 — Price, Financials & Analyst Targets | Alpha Lenz